1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
659C8D778ABA8BCC30025893C003A8876
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-omnichannel-engagement-in-medical-affairs-stakeholder-communication-value-delivery?opendocument
18
19opendocument
2034.225.194.102
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Affairs Excellence

Omnichannel Engagement in Medical Affairs: Stakeholder Communication and Value Delivery

ID: 5749


Features:

12 Info Graphics

12 Data Graphics

230+ Metrics

17 Narratives


Pages/Slides: 31


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Omnichannel Engagement in Medical Affairs: Stakeholder Communication and Value Delivery”

STUDY OVERVIEW

As Medical Affairs is increasingly adopting digital tools for stakeholder engagement and value delivery, it is important to develop an omnichannel strategy to deliver a consistent, personalized experience to stakeholders across channels. However, with omnichannel being a relatively new phenomenon, it is important that Medical Affairs leaders identify the right communication channels and establish key performance indicators to evaluate program effectiveness.

Best Practices, LLC undertook this benchmarking research to examine Medical Affairs’ advances in omnichannel engagement. This study probes and profiles direct and indirect communication channels for omnichannel engagement, program goals, and newly-formed KPIs for program evaluation.

KEY TOPICS

  • High-Impact Channels for Omnichannel Engagement
  • Tools and Platforms Used for Omnichannel Execution
  • Delivering Value across Medical Affairs
  • Omnichannel Engagement KPIs

KEY METRICS

  • How valuable are listed direct communication channels (targeting specific individuals and audiences) as part of the omnichannel engagement program?
  • How valuable are listed indirect communication channels (access to all) as part of the omnichannel engagement program?
  • Please rate the effectiveness of profiling characteristics
  • Please indicate whether each of the listed groups lead, support, or have no involvement in sharing insights generated through omnichannel engagement
  • To what extent have benchmark organizations been successful in standardizing omnichannel engagement KPIs?

SAMPLE KEY FINDINGS

  • Leading companies find high impact across many channels and touchpoints: No one channel is perfect for all segments or individual targets, but each can contribute “a piece to the puzzle” of forging a better overall user experience. Leading companies achieve much higher impact than other emerging companies in these engagement channels: MSL virtual presentations, data slides and on/off-label presentations, Med Info letters, unbranded websites, publications, HCP portals, and social media.

METHODOLOGY

Best Practices, LLC engaged 57 leaders from 43 biopharma companies in this research through a benchmark survey.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Service; Chemical; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Amgen; Apellis Pharmaceuticals; Astellas; AstraZeneca; Baxter International; Bayer; Biogen Idec; Boehringer Ingelheim; B. Braun; Cara Therapeutics; Chiesi; Cipla; Daiichi Sankyo; Eisai; Eli Lilly and Company; EVERSANA; Fidia; Genentech; General Electric; Gilead Sciences; GlaxoSmithKline ; Heron Therapeutics; Ipsen; Jazz Pharmaceuticals; Kyowa Kirin; Lupin; Lundbeck; Medexus Pharmaceuticals; Merck; Novartis; Novo Nordisk; Orchard Therapeutics; Pixacore; Provention Bio; Radius Health; Inc.; Roche; Sandoz; Sanofi; Santen; Supernus; Takeda Pharmaceuticals; Taysha Gene Therapies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.